Upgrades/Downgrades
Updated: 25-Jun-26 16:30 ET
| Upgrades | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Xylem | XYL | Jefferies | Hold » Buy | $140 | |
| UWM Holdings | UWMC | Keefe Bruyette | Mkt Perform » Outperform | $3.75 | |
| Qualcomm | QCOM | Morgan Stanley | Underweight » Equal-Weight | $231 | |
| Primoris Services | PRIM | Goldman | Sell » Neutral | $102 | |
| Nomura Holdings | NMR | BofA Securities | Neutral » Buy | $10.20 | |
| L'Oreal | LRLCY | Citigroup | Neutral » Buy | ||
| Keurig Dr Pepper | KDP | Barclays | Equal Weight » Overweight | $36 | |
| ICON plc | ICLR | RBC Capital Mkts | Sector Perform » Outperform | $185 | |
| Canadian Nat'l Rail | CNI | Evercore ISI | In-line » Outperform | $124 | |
| Iberdrola SA | IBDRY | Erste Group | Hold » Buy | ||
| Micron | MU | Erste Group | Hold » Buy | ||
| Workday | WDAY | Monness Crespi & Hardt | Neutral » Buy | $150 | |
|
|
|||||
| Downgrades | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Swatch | SWGAY | Bernstein | Outperform » Mkt Perform | ||
| PVH | PVH | BofA Securities | Neutral » Underperform | $70 | |
| Identiv | INVE | Craig Hallum | Buy » Hold | $3.10 | |
| Brown-Forman | BF.B | Barclays | Overweight » Equal Weight | $27 | |
| Apollo Commercial Real Estate | ARI | BTIG Research | Buy » Neutral | ||
| Affirm | AFRM | Morgan Stanley | Overweight » Equal-Weight | $79 | |
| NextEra Energy | NEE | Erste Group | Buy » Hold | ||
| Eni S.p.A. | E | Erste Group | Buy » Hold | ||
| BAE Systems | BAESY | Erste Group | Buy » Hold | ||
|
|
|||||
| Coverage Initiated | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| VICI Properties | VICI | RBC Capital Mkts | Sector Perform | $29 | |
| Velo3D | VELO | Needham | Buy | $33 | |
| Tonix Pharma | TNXP | Raymond James | Strong Buy | $26 | |
| Southside Banc | SBSI | The Benchmark Company | Hold | ||
| South Plains Financial | SPFI | The Benchmark Company | Buy | $53 | |
| SmartFinancial | SMBK | The Benchmark Company | Buy | $54 | |
| Shift4 Payments | FOUR | Loop Capital | Hold | $40 | |
| Qiagen | QGEN | Kepler | Hold | $38.60 | |
| Prosperity Bancshares | PB | The Benchmark Company | Hold | ||
| Pinnacle Finl | PNFP | The Benchmark Company | Buy | $132 | |
| Oklo Inc. | OKLO | Guggenheim | Neutral | ||
| MapLight Therapeutics | MPLT | Raymond James | Strong Buy | $46 | |
| JFrog | FROG | The Benchmark Company | Buy | $100 | |
| Intel | INTC | Goldman | Neutral | $150 | |
| Home Bancshares | HOMB | The Benchmark Company | Hold | ||
| Hancock Whitney | HWC | The Benchmark Company | Buy | $84 | |
| First Internet Bancorp | INBK | The Benchmark Company | Buy | $33 | |
| First Financial Bankshares | FFIN | The Benchmark Company | Buy | $39 | |
| FB Financial | FBK | The Benchmark Company | Buy | $64 | |
| Exagen | XGN | Roth Capital | Buy | $8 | |
| Equity Bancshares | EQBK | The Benchmark Company | Buy | $57 | |
| Enact Holdings | ACT | RBC Capital Mkts | Sector Perform | $47 | |
| CoreWeave | CRWV | Rosenblatt | Buy | $250 | |
| Castle Biosciences | CSTL | Roth Capital | Buy | $40 | |
| Boost Run | BRUN | BTIG Research | Buy | $45 | |
| BOK Financial | BOKF | The Benchmark Company | Hold | ||
| Biodesix | BDSX | Roth Capital | Buy | $32 | |
| Targa Resources | TRGP | Erste Group | Buy | ||
| Mitsubishi Financial | MUFG | Erste Group | Buy | ||
| Whitehawk Therapeutics | WHWK | B. Riley Securities | Buy | $10 | |
| Alpha and Omega Semi | AOSL | Lake Street | Buy | $58 | |
|
|
|||||
| Coverage Resumed | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Exelixis | EXEL | Truist | Hold | $54 | |
| Blue Bird | BLBD | Roth Capital | Buy | $94 | |
|
|
|||||
| Coverage Reiterated/Price Tgt Changed* | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| DraftKings | DKNG | Citizens | Mkt Outperform | $34 » $36 | |
| Atlassian | TEAM | BMO Capital Markets | Outperform | $105 » $95 | |
| Micron | MU | Needham | Buy | $1550 » $1650 | |
|
|
|||||
| (a) Brokerage firm initiating coverage participated in underwriting the recent IPO. |
| (b) Brokerage firm resumes coverage. |
| (c) Brokerage firm participated in the secondary offering. |
| * This list of reiterations/target changes is not comprehensive. |